AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
2
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
3
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
4
After $400M cyber exit, ex-IntSights CEO raises $11M to build AI app for personalized sports highlights
5
Why Apple paid billions for a company with no revenue
More news

Biotech

20 stories about Biotech
בניין ה בורסה משכן חדש רחוב אחוזת בית תל אביב

Biomed Company CartiHeal Considers a Nasdaq IPO

26.02.20|Golan Hazani
The company is looking to raise between $60 million and $80 million according to a valuation of $300 million to $400 million and has already hired Credit Suisse and Jefferies for this purpose, according to two people familiar with the matter
ד"ר יאיר שינדל מוסף שבועי 13.2.20

Healthtech Is Israel’s Next Growth Engine, Says Venture Capitalist

21.02.20| Sophie Shulman
Yair Schindel was a decorated army medic, a doctor, an entrepreneur, and the head of Israel’s National Digital Bureau. Now, he manages Israeli venture capital fund aMoon and wants to turn Israel into a healthtech empire
איל ליפשיץ פלגרין

Peregrine Ventures Raises Fourth $115 Million Fund

09.12.19|CTech
The Israeli medtech venture firm now has over $200 million under management
סטיבן מנושין סטיבן מנוצ'ין שר האוצר ארה"ב

Steven Mnuchin, Israeli Health Officials Discuss Establishment of Israeli FDA Branch

29.10.19|Sophie Shulman
The FDA, which approves all medical devices and formulations in the U.S., has very few branches outside of the U.S.
נאסדק

Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO

15.10.19|CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
פנאי נתח בשר

Ophectra Signs Merger Deal With Meat Bioprinting Company MeaTech

03.10.19|Ori Galor and Tzally Greenberg
The announcement comes a week after Ophectra announced that its merger deal with cannabis company Hi Pharma fell through
בורסה בורסת תל אביב 5

New York-Based Financial Services Firm Jefferies to Join Tel Aviv Stock Exchange

02.06.19|Raheli Bindman
As a remote member, Jefferies’ international clients will gain better access to Israeli tech and biotech companies, creating more investment opportunities
שם: מעבדה ביוטק וושי אפטק Lab Biotech WuXi AppTec

RM Global Raises Additional $34 Million for Israel-Based Biopharma Investment Fund

09.04.19|CTech
The fund's portfolio is made up of 11 startups operating at the company’s FutuRx biotech accelerator in the central Israeli town of Ness Ziona
מוסף רפואה מבחנה מבחנות תרופה תרופות בית חולים

Can-Fite BioPharma to Raise $3.2 Million in Direct Offering

04.04.19|CTech
The NYSE and Tel Aviv-listed company develops small molecule drugs used in the treatment of liver and inflammatory diseases and cancer
נאסדק

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
נאסד"ק וול סטריט

Anchiano Therapeutics Stock Falls on Nasdaq IPO

13.02.19|Lilach Baumer
The cancer treatment company priced its ADSs at $11.5 per unit, expecting proceeds of $30.5 million
נאסדק

Cancer Screening Company Check-Cap Crashes on $7.5 Million Nasdaq Direct Offering

05.02.19|Lilach Baumer
The clinical-stage company announced the discounted offering Monday, closing 27.62% down on the exchange
בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason

10.01.19|Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
חברת תרופות סלג'ן סלג'ין Celgene משרדים סן דייגו קליפורניה

Celgene Backs Immunotherapy Company Biond Biologics

08.01.19|Meir Orbach
Biond develops immunotherapies for cancer and autoimmune diseases
אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer
The investment is part of a licensing option agreement signed between the two companies
חקר DNA מעבדה

Lonza Opens Israeli Innovation Center

20.11.18|Lilach Baumer
The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent
default image

Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas

12.11.18|Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
default image

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
תל אביב קו רקיע Tel Aviv Skyline

Israel to Help Biotech Companies Go from Research to Manufacturing

04.11.18|Omri Milman
Companies looking to set up manufacturing facilities could receive grants covering 20%-30% of the costs
Previous ArticlesMore Articles